Clinical trial
Randomized, Multicentric, Controlled Study on the Daily Use of Lipikar Balm AP From Birth in Infants at High Risk of Developing Atopic Dermatitis
NCT01577628 is registered in ClinicalTrials.gov with Cosmetique Active International as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Randomized, Multicentric, Controlled Study on the Daily Use of Lipikar Balm AP From Birth in Infants at High Risk of Developing Atopic Dermatitis
- Lead sponsor
- Cosmetique Active International
- Phase
- Not applicable
- Overall status
- Terminated
- Start date
- June 30, 2012
- Completion date
- February 28, 2013
- Enrollment
- 2 (actual)
- Sites
- 4
Conditions
As the registry lists them; a condition with its own page is linked.